Weigao Medical Polymer Sets AGM to Approve Dividend and Tightened Share-Issue Mandate

Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) has shared an update.

Shandong Weigao Group Medical Polymer Company Limited has convened its 2026 annual general meeting for 29 May in Weihai, Shandong, where shareholders will review and approve the audited 2025 financial statements, the board and Supervisory Committee reports, and a proposed final dividend of RMB0.06 per share. Investors will also vote on reappointing Deloitte Touche Tohmatsu as auditor, authorising director remuneration, and granting the board a tightened general mandate to issue up to 10% of existing H shares and domestic shares at a maximum 10% discount, which may influence the company’s future capital-raising flexibility and share dilution profile.

The proposed general mandate sets stricter pricing terms than Hong Kong listing rules by capping any discount at 10%, signalling a cautious approach toward equity issuance that may be seen as shareholder-friendly. At the same time, maintaining issuance capacity for both Hong Kong-listed and domestic shares underscores Weigao’s intent to preserve funding optionality for expansion and operations, with dividend continuity and auditor reappointment pointing to an emphasis on financial stability and governance continuity.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a PRC-based medical device manufacturer specializing in medical polymer products. The company is listed in Hong Kong and focuses on both domestic and overseas capital markets through its H shares and non-listed domestic shares, reflecting its role as a significant player in China’s medical consumables sector.

Average Trading Volume: 21,600,914

Technical Sentiment Signal: Sell

Current Market Cap: HK$16.82B

See more data about 1066 stock on TipRanks’ Stock Analysis page.